#Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, '#Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in #India for the treatment of moderate to severe cases of #Covid19. Photo: IANS '
#Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in #India for the treatment of moderate to severe cases of #Covid19.
Photo: IANS (Representational image) pic.twitter.com/4wvZjcNxyi— IANS Tweets (@ians_india) June 11, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jun 11, 2021 11:52 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
